Allegheny Health Network Offers T-VEC Virus-Based Treatment for Advanced Melanoma
Share Article
Pittsburgh-based Allegheny Health Network is offering patients with advanced melanoma treatment with an oncolytic (cancer-killing) virus called Imlygic or T-VEC. It is injected directly into the tumor, where it works by replicating inside the cancer cells.
AHN surgical oncologist Howard Edington, MD, talks with patient Paul Kirsch prior to treatment with T-VEC
“Unlike other therapies for advanced melanoma, T-VEC is usually well tolerated and is suitable for many patients, including the elderly. It also has a “bystander effect,” killing nearby tiny lesions in addition to the primary tumor.” - Howard Edington, MD, AHN surgical oncologist